Table 1.

Case Descriptions of Mucormycosis Patients.

Age Sex Comorbidities Mucormycosis Extent Time to Recurrence after Initial CAM Therapy (days) Extent of Present Disease Intraoperative CSF Leak
62 M DM + HTN SNP 29 Left frontal sinus, outer frontal sinus table erosion, dura free, brain free No
52 M DM + HTN + hypothyroidism SNOC 10 Bilateral frontal sinus, erosion of both frontal sinus tables, dural enhancement, prefrontal cortex involved Yes
30 M DM SNO 19 Left frontal sinus, outer frontal sinus table erosion, dura free, brain free No
43 M DM SNO 16 Bilateral frontal sinus, erosion of both frontal sinus tables, dural enhancement, prefrontal cortex involved Yes
33 M DM SNC 26 Left frontal sinus, inner frontal sinus table erosion, dura free, brain free No
40 F DM + HTN SN 26 Left frontal sinus, outer frontal sinus table erosion, dura free, brain free No
45 M DM + HTN SN 31 Left frontal sinus, outer frontal sinus table erosion, dura free, brain free No
43 M DM SNP 33 Left frontal sinus, inner frontal sinus table erosion, dura free, brain free No
46 M DM SN 14 Left frontal sinus, outer frontal sinus table erosion, dura free, brain free No
39 M DM + HTN + hypothyroidism SN 16 Left frontal sinus, outer frontal sinus table erosion, dura free, brain free No

CAM, COVID-19-acquired mucormycosis; CSF, cerebrospinal fluid; DM, diabetes mellitus; F, female; HTN, hypertension; M, male; SN, sinonasal; SNC, sino-naso-cerebral; SNO, sino-naso-orbital; SNOC, sino-naso-orbito-cerebral; SNP, sino-naso-palatal.

RMMJ Rambam Maimonides Medical Journal Rambam Health Care Campus 2022; 13(4): e0025. ISSN: 2076-9172
Published online 2022 October 27. doi: 10.5041/RMMJ.10484
Copyright: © 2022 Mehta et al.